<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the present study, we have investigated the effect of <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> hormones on neutrophil-mediated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell cytostasis and found that <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> and a synthetic hormone, <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> (Dex), inhibited cytostasis in the presence or absence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of Dex was completely reversed by a <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, RU38486 </plain></SENT>
<SENT sid="2" pm="."><plain>To clarify the underlying mechanisms, we examined effects of Dex on the binding avidity of beta2 integrin on the neutrophil surface and how these might in turn affect neutrophil-to-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell binding </plain></SENT>
<SENT sid="3" pm="."><plain>Dex was found to inhibit these neutrophil properties, and RU38486 completely suppressed both forms of Dex inhibition </plain></SENT>
<SENT sid="4" pm="."><plain>Taken together, our findings suggest that <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> hormone inhibition of neutrophil-mediated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell cytostasis is at least partially due to a lowering of the ligand binding avidity of beta2 integrin on the neutrophil surface </plain></SENT>
</text></document>